Value of Clinical Cases

March 15, 2023

Share This Page

Value of Clinical Cases

March 15, 2023

Evidence-based solutions for professional and financial advancement.

You have the Cases, and RegenMed has time, tools and expertise toextract their true value. If you’ll share your objectives, we will present a turnkey, burden-free solution comprising one or more of:

Study Design
Patient-Reported Outcomes
Patient Engagement
Electronic Data Capture
Peer-to-Peer Collaboration
Social Media Management
Ethical Industry Intermediation
Compliance
IRB’s and Ethics Committees

Share This Page

Value of Clinical Cases

March 15, 2023

Evidence-based solutions for professional and financial advancement.

Study Design
Patient-Reported Outcomes
Patient Engagement
Electronic Data Capture
Peer-to-Peer Collaboration
Social Media Management
Ethical Industry Intermediation
Compliance
IRB’s and Ethics Committees

Share This Page

Read The Latest

October 16, 2024

Real-World Evidence For Select Peptides

Ozempic™, Wegovy™ and similar “GLP-1” drugs have underscored the importance of peptides. There are over 7,000 known peptides in the human body, each with its own characteristics and potential benefits and side effects.

October 10, 2024

Physicians-Owned Circles

RegenMed is now enabling independent clinicians to earn supplemental revenue and increase practice equity value through Physicians-Owned Circles. POCs are based on a simple premise – manufacturers, payers, self-insured employer groups and other healthcare constituencies...

October 7, 2024

Reapplix Private Circle For Diabetic Foot Ulcers

Reapplix, an international wound care company, has recently launched a RegenMed Private Circle aggregating clinical and long-term outcomes data on its personalized diabetic foot ulcer product. The diabetic foot ulcer market value is estimated at $5.2 billion.